CrushSCI.com
提供学术论文选刊润色服务
Journal of Hematology & Oncology 期刊封面 医学
返回期刊列表

Review Cycle Records

Journal of Hematology & Oncology

Springer SCIE OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
76平均天数
71.5中位天数
47最短天数
126最长天数
1182025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

47 天

The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 2026

作者Serena Pillozzi; Elisa Giommoni; Giulia Petroni; Daniele Rossini; Daniele Lavacchi; Marco Brugia; Andrea Galli; Lorenzo Antonuzzo

作者单位1. Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, Italy; 2. Pancreas Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 3. Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 4. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

PDF源文件 DOI 网页
72 天

Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level data

作者Ming-Yu Lai; Hao-Xiang Wu; Ming-Ming He; Wen-Long Guan; Sheng Xu; Han Hu; Ya-Ling Xu; Feng-Hua Wang; Rui-Hua Xu; Miao-Zhen Qiu

作者单位1. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China; 2. Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, China; 3. Department of Clinical Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China; 4. Global Statistics and Data Science, BeOne Medicines, Ltd., Shanghai, China; 5. Clinical Biomarker Sciences and CDx Development, BeOne Medicines, Ltd., Beijing, China; 6. Clinical Development, BeOne Medicines, Ltd., Shanghai, China

PDF源文件 DOI 网页
101 天

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment

作者Monika Szczepanowski; Johanna Richter; Sonja Bendig; Lorenz Bastian; Miriam Kelm; Veronika Beck; Thomas Beder; Guranda Chitadze; Michaela Kotrová; Johannes Duell; Christoph Faul; Johannes Gärtner; Alina Hartmann; Britta Kehden; Eva Maria Murga Penas; Martin Neumann; Matthias Ritgen; Wiebke Schrader; Björn Steffen; Heiko Trautmann; Andreas Viardot; Thomas Burmeister; Claudia D. Baldus; Stefan Schwartz; Nicola Gökbuget; Monika Brüggemann

作者单位1. Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Kiel, Germany; 2. University Cancer Center Schleswig-Holstein (UCCSH), Kiel, Germany; 3. Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 4. Clinical Research Unit ’CATCH ALL’ (KFO 5010), Kiel, Germany; 5. Department of Internal Medicine II, Würzburg University Hospital, University of Würzburg, Würzburg, Germany; 6. Internal Medicine II, University Hospital and Comprehensive Cancer Center Tübingen, Universitätsklinikum Tübingen, Tübingen, Germany; 7. Department of Medicine 5, Oncology, Hematology and Bone Marrow Transplantation Unit, Klinikum Nürnberg Nord, Nürnberg, Germany; 8. Institute of Human Genetics, University Medical Center Schleswig- Holstein (UKSH), Lübeck, Germany; 9. Medicine Department II, Johann Wolfgang Goethe University, Frankfurt, Germany; 10. Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany; 11. Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum, Campus Virchow Klinikum, Charité - Universitätsmedizin, Berlin, Germany; 12. Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin , Berlin, Germany; 13. Department of Hematology, Oncology and Tumor Immunology, Berlin, Germany; 14. Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 15. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

PDF源文件 DOI 网页
58 天

Emerging artificial intelligence advances in oncology: latest updates from the 2026 AACR annual meeting

作者Yan-Ruide Li; Zhengyao Shao; Haochen Nan

作者单位1. Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, USA; 2. Department of Bioengineering, University of California, Los Angeles, USA; 3. Goodman-Luskin Microbiome Center, University of California, Los Angeles, USA; 4. Department of Pharmacology, University of California San Diego, La Jolla, USA

PDF源文件 DOI 网页
66 天

Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer

作者Chang Liu; Hongxi Zeng; Jiarui Li; Panpan Zhang; Dan Liu; Miao Zhang; Ran Xue; Jifang Gong; Xiaotian Zhang; Yu Sun; Lin Shen; Changsong Qi

作者单位1. Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute, Beijing, China; 2. Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China; 3. Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China; 4. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China; 5. Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute, Beijing, China

PDF源文件 DOI 网页
71 天

Large language model-guided CAR-T in silico platform for cytokine optimization in liver cancer with low antigen density

作者Haochen Nan; Xinyuan Shen; Youcheng Yang; Shubing Wang; Yan-Ruide Li

作者单位1. Department of Bioengineering, University of California, Los Angeles, USA; 2. Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, USA; 3. Goodman-Luskin Microbiome Center, University of California, Los Angeles, USA

PDF源文件 DOI 网页
126 天

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88 L265P -induced PIM1 stability

作者Yan Yuan; Bo Dai; Haoshu Zhong; Jiajun Zheng; Zhen Fan; Di Chen; Qian Wang; Hao Wu; Yuan Li; Ping Zhu; Tianling Ding; Shu Wang; Kunpeng Wu; Yu Zhang; Zhenhua Wang; Rui Feng; Fengping Zhu; Kang Zheng; Zhiyong Qin; Bojie Yang; Hong Chen; Xiaolei Lin; Yu Yao; Dongxiao Zhuang; Zhifeng Shi; Ying Mao; Tong Chen

作者单位1. Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China; 2. Center of Precision Medicine for Blood Diseases, Fudan University, Shanghai, China; 3. Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China; 4. Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China; 5. Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China; 6. Department of Pathology, Huashan Hospital, Fudan University, Shanghai, China; 7. Institute of Medicine, Huashan Hospital, Fudan University, Shanghai, China; 8. School of Data Science, Fudan University, Shanghai, China

PDF源文件 DOI 网页
50 天

Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meeting

作者Yagya Ahlawat; Heng Jiang; Delong Liu

作者单位1. Division of Hematology and Oncology, Westchester Medical Center, New York Medical College, Valhalla, USA; 2. Department of Internal Medicine, Westchester Medical Center, New York Medical College, Valhalla, USA

PDF源文件 DOI 网页
75 天

Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meeting

作者Pritika Sharma; Heng Jiang; Delong Liu

作者单位1. Division of Hematology and Oncology, Westchester Medical Center and New York Medical College, Valhalla, USA; 2. Department of Internal Medicine, Westchester Medical Center, Valhalla, USA

PDF源文件 DOI 网页
94 天

Circulating tumor DNA in breast cancer: updates from SABCS 2025

作者Iris Zhi; Xianghui Zou; Min Sun; Nancy Chan; Naomi Ko; Neil Vasan; Shridar Ganesan; Cynthia Ma

作者单位1. Division of Hematology and Medical Oncology, NYU Langone Perlmutter Cancer Center, NYU Grossman Long Island School of Medicine, Mineola, USA; 2. Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, USA; 3. Division of Hematology and Medical Oncology, NYU Langone Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, USA; 4. Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, USA

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。